Nomura Holdings, Inc. (NMR) P/E Ratio History
Historical price-to-earnings valuation from 2003 to 2026
Loading P/E history...
NMR Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 6, 2026, Nomura Holdings, Inc. (NMR) trades at a price-to-earnings ratio of 10.4x, with a stock price of $7.89 and trailing twelve-month earnings per share of $122.54.
The current P/E is 10433% above its 5-year average of 0.1x. Over the past five years, NMR's P/E has ranged from a low of 0.1x to a high of 0.3x, placing the current valuation at the 100th percentile of its historical range.
Compared to the Financial Services sector median P/E of 13.3x, NMR trades at a 22% discount to its sector peers. The sector includes 779 companies with P/E ratios ranging from 0.0x to 197.4x.
The PEG ratio of 0.53 (P/E divided by 7% EPS growth) suggests the stock may be undervalued relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.
Relative to the broader market, NMR trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our NMR DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
NMR P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $301B | 23.8 | 2.67 | +53% | |
| $285B | 22.7 | 1.62 | +77% | |
| $137B | 23.6 | 21.34 | +23% | |
| $59B | 8.4Lowest | 0.07Best | +126%Best | |
| $201B | 17.4 | 0.55 | +28% | |
| $404B | 13.9 | 0.91 | +19% | |
| $224B | 21.5 | - | +47% | |
| $834B | 15.7 | 1.21 | +22% | |
| $135B | 11.0 | 0.89 | +26% | |
| $105B | 19.0 | 1.30 | +31% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
NMR Historical P/E Data (2003–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q2 | Mon Oct 27 2025 00:00:00 GM | $7.08 | $120.97 | 0.1x | -80% |
| FY2026 Q1 | Mon Jun 30 2025 00:00:00 GM | $6.58 | $122.74 | 0.1x | -82% |
| FY2025 Q4 | Mon Mar 31 2025 00:00:00 GM | $6.15 | $111.00 | 0.1x | -81% |
| FY2025 Q3 | $5.79 | $105.72 | 0.1x | -81% | |
| FY2025 Q2 | Mon Sep 30 2024 00:00:00 GM | $5.22 | $88.74 | 0.1x | -80% |
| FY2025 Q1 | Sun Jun 30 2024 00:00:00 GM | $5.78 | $67.69 | 0.1x | -71% |
| FY2024 Q4 | Sun Mar 31 2024 00:00:00 GM | $6.42 | $52.73 | 0.1x | -59% |
| FY2024 Q3 | Sun Dec 31 2023 00:00:00 GM | $4.51 | $37.01 | 0.1x | -59% |
| FY2024 Q2 | Sat Sep 30 2023 00:00:00 GM | $4.02 | $42.42 | 0.1x | -68% |
| FY2024 Q1 | Fri Jun 30 2023 00:00:00 GM | $3.83 | $36.63 | 0.1x | -65% |
| FY2023 Q4 | Fri Mar 31 2023 00:00:00 GM | $3.80 | $29.35 | 0.1x | -56% |
| FY2023 Q3 | Sat Dec 31 2022 00:00:00 GM | $3.75 | $36.94 | 0.1x | -66% |
Average P/E for displayed period: 0.3x
Full NMR Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See NMR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NMR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NMR vs BRK-A
Side-by-side business, growth, and profitability comparison vs Berkshire Hathaway Inc..
Start ComparisonNMR — Frequently Asked Questions
Quick answers to the most common questions about buying NMR stock.
Is NMR stock overvalued or undervalued?
NMR trades at 10.4x P/E, above its 5-year average of 0.1x. The 100th percentile ranking indicates a premium to historical valuation.
How does NMR's valuation compare to peers?
Nomura Holdings, Inc. P/E of 10.4x compares to sector median of 13.3x. The discount suggests lower growth expectations or higher risk.
What is NMR's PEG ratio?
NMR PEG ratio is 0.53. Below 1.0 indicates valuation is supported by earnings growth rate. Historical P/E data spans 2003-2026.